Editas Medicine Inc (EDIT)
2.435
+0.06
(+2.74%)
USD |
NASDAQ |
Nov 22, 15:36
Editas Medicine Shareholders Equity (Quarterly): 175.63M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 175.63M |
| June 30, 2024 | 232.01M |
| March 31, 2024 | 294.40M |
| December 31, 2023 | 349.10M |
| September 30, 2023 | 360.46M |
| June 30, 2023 | 399.92M |
| March 31, 2023 | 317.47M |
| December 31, 2022 | 360.68M |
| September 30, 2022 | 414.74M |
| June 30, 2022 | 465.41M |
| March 31, 2022 | 512.76M |
| December 31, 2021 | 553.64M |
| September 30, 2021 | 586.79M |
| June 30, 2021 | 613.36M |
| March 31, 2021 | 638.00M |
| December 31, 2020 | 393.59M |
| September 30, 2020 | 441.15M |
| June 30, 2020 | 426.77M |
| March 31, 2020 | 234.57M |
| Date | Value |
|---|---|
| December 31, 2019 | 262.44M |
| September 30, 2019 | 209.99M |
| June 30, 2019 | 193.06M |
| March 31, 2019 | 217.16M |
| December 31, 2018 | 236.16M |
| September 30, 2018 | 224.45M |
| June 30, 2018 | 231.33M |
| March 31, 2018 | 247.52M |
| December 31, 2017 | 208.08M |
| September 30, 2017 | 177.79M |
| June 30, 2017 | 185.00M |
| March 31, 2017 | 206.46M |
| December 31, 2016 | 134.61M |
| September 30, 2016 | 170.18M |
| June 30, 2016 | 187.33M |
| March 31, 2016 | 201.36M |
| December 31, 2015 | -83.11M |
| September 30, 2015 | 127.62M |
| December 31, 2014 | -15.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
175.63M
Minimum
Sep 2024
638.00M
Maximum
Mar 2021
401.64M
Average
396.75M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 662.47M |
| EyePoint Pharmaceuticals Inc | 218.73M |
| Cassava Sciences Inc | 166.64M |
| Adverum Biotechnologies Inc | 144.12M |
| Regenxbio Inc | 301.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.57M |
| Total Liabilities (Quarterly) | 151.93M |
| Current Ratio | 3.747 |